Edition:
United States

Rexahn Pharmaceuticals Inc (RNN.A)

RNN.A on American Stock Exchange

0.26USD
26 Jul 2016
Change (% chg)

$-0.00 (-1.23%)
Prev Close
$0.26
Open
$0.25
Day's High
$0.26
Day's Low
$0.25
Volume
68,600
Avg. Vol
76,579
52-wk High
$0.65
52-wk Low
$0.24

RNN.A

Chart for RNN.A

About

Rexahn Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development and commercialization of treatments for cancer. The Company's clinical-stage drug candidates in active development include Archexin, RX-3117 and Supinoxin (RX-5902). Archexin is a potent inhibitor of the protein... (more)

Overall

Beta: 0.17
Market Cap(Mil.): $55.40
Shares Outstanding(Mil.): 213.17
Dividend: --
Yield (%): --

Financials

  RNN.A Industry Sector
P/E (TTM): -- 41.28 37.71
EPS (TTM): -0.08 -- --
ROI: -57.04 -9.20 14.43
ROE: -70.28 -9.24 15.61

BRIEF-Rexahn Pharma Q1 loss per share $0.02

* Expects cash investments as of march 31, 2016 will be sufficient to fund requirements for current activities into h2 2017

May 09 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Ford Investor Services, Inc.
$12.00
Provider : MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.